Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
05:30pm, Tuesday, 21'st Jan 2020
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im
Edited Transcript of ICCC earnings conference call or presentation 11-Nov-19 9:30pm GMT
07:25pm, Monday, 06'th Jan 2020
Q3 2019 ImmuCell Corp Earnings Call
Hedge Funds Have Never Been More Bullish On ImmuCell Corporation (ICCC)
06:21pm, Sunday, 22'nd Dec 2019
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards
Is ImmuCell (NASDAQ:ICCC) Weighed On By Its Debt Load?
04:38pm, Thursday, 19'th Dec 2019
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Does ImmuCell Corporation (NASDAQ:ICCC) Have A Volatile Share Price?
02:37pm, Tuesday, 12'th Nov 2019
If you own shares in ImmuCell Corporation (NASDAQ:ICCC) then it's worth thinking about how it contributes to the...
ImmuCell Q3 EPS $(0.07) Up From $(0.17) YoY, Sales $2.97M Up From $2.154M YoY
12:00am, Monday, 11'th Nov 2019The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
11:58am, Wednesday, 09'th Oct 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-week highs on Tuesday. Down In The Dumps (Biotech st
